FDA Import Refusal AEK-8531849-9/12/1 — Cipla Limited

Cipla Limited — FEI 3002806691

The FDA refused shipment AEK-8531849-9/12/1 from Cipla Limited (India) on June 11, 2025. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
June 11, 2025
Country
India
Product Category
Drugs and Biologics
Product Code
61JDY08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
Charges
75